These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19327866)

  • 41. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.
    Jakub JW; Huebner M; Shivers S; Nobo C; Puleo C; Harmsen WS; Reintgen DS
    Ann Surg Oncol; 2009 Aug; 16(8):2245-51. PubMed ID: 19517194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Impact of micrometastasis in pathologically negative lymph node on staging and prognosis of non-small cell lung cancers].
    Zheng R; Ge D; Qiao Y; Shi M
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):41-3. PubMed ID: 11977636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Total number of resected lymph nodes predicts survival in esophageal cancer.
    Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
    Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.
    Casali C; Stefani A; Natali P; Rossi G; Morandi U
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
    Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
    Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis.
    Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F
    Clin Lung Cancer; 2020 Sep; 21(5):464-471.e1. PubMed ID: 32389508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†.
    Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Spaggiari L; Ratto GB; Filosso PL; Facciolo F
    Eur J Cardiothorac Surg; 2019 Mar; 55(3):405-412. PubMed ID: 30202953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.
    Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL
    BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The number of resected lymph nodes (nLNs) combined with tumor size as a prognostic factor in patients with pathologic N0 and Nx non-small cell lung cancer.
    Yang M; Cao H; Guo X; Zhang T; Hu P; Du J; Liu Q
    PLoS One; 2013; 8(9):e73220. PubMed ID: 24023836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic score for survival with pulmonary carcinoids: the importance of associating clinical with pathological characteristics.
    Chiappetta M; Sperduti I; Ciavarella LP; Leuzzi G; Bria E; Mucilli F; Lococo F; Filosso P; Ratto G; Spaggiari L; Facciolo F; Margaritora S
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):315-323. PubMed ID: 32747930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
    Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
    Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors.
    Pilotto S; Sperduti I; Novello S; Peretti U; Milella M; Facciolo F; Vari S; Leuzzi G; Vavalà T; Marchetti A; Mucilli F; Crinò L; Puma F; Kinspergher S; Santo A; Carbognin L; Brunelli M; Chilosi M; Scarpa A; Tortora G; Bria E
    J Thorac Oncol; 2015 Sep; 10(9):1341-1348. PubMed ID: 26200453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum uric acid to lymphocyte ratio: A novel prognostic biomarker for surgically resected early-stage lung cancer. A propensity score matching analysis.
    Yang Z; Li S; Zhao L; Lv W; Ju J; Zhang W; Li J; Che G
    Clin Chim Acta; 2020 Apr; 503():35-44. PubMed ID: 31926813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of a prognostic model including the number of harvested lymph-nodes in the setting of non-small cell lung cancer patients undergoing curative resection: a multicenter analysis.
    Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Ratto GB; Lococo F; Filosso PL; Spaggiari L; Facciolo F
    Minerva Surg; 2022 Jun; 77(3):214-220. PubMed ID: 34338459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment.
    Pilotto S; Sperduti I; Leuzzi G; Chiappetta M; Mucilli F; Ratto GB; Lococo F; Filosso PL; Spaggiari L; Novello S; Milella M; Santo A; Scarpa A; Infante M; Tortora G; Facciolo F; Bria E
    J Thorac Oncol; 2018 Apr; 13(4):568-575. PubMed ID: 29269009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the prognostic relevance of the recommended minimum number of lymph nodes in colorectal cancer-a propensity score analysis.
    Ramser M; Lobbes LA; Warschkow R; Viehl CT; Lauscher JC; Droeser RA; Kettelhack C; Zuber M; Weixler B
    Int J Colorectal Dis; 2021 Apr; 36(4):779-789. PubMed ID: 33454816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of metabolic syndrome and its components on recurrence and survival in early-stage non-small cell lung cancer.
    Wen YS; Zhang XW; Qin RQ; Zhang LJ
    Med Oncol; 2015 Jan; 32(1):423. PubMed ID: 25476482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis.
    Luchini C; Veronese N; Nottegar A; Cheng M; Kaneko T; Pilati C; Tabbò F; Stubbs B; Pea A; Bagante F; Demurtas J; Fassan M; Infante M; Cheng L; Scarpa A
    Virchows Arch; 2018 Jun; 472(6):939-947. PubMed ID: 29392400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.